Psychedelic microdosing: A new frontier for treating ADHD symptoms and emotional dysregulation

 ADHD in the News 2024-05-02

A new study published in the journal European Psychiatry has shed light on an unconventional approach to managing symptoms associated with Attention-Deficit Hyperactivity Disorder (ADHD). The findings suggest that small, repeated doses of substances like psilocybin and lysergic acid diethylamide (LSD) could potentially help reduce ADHD symptoms and enhance some aspects of emotion regulation. These findings could pave the way for new treatments that focus not only on the primary symptoms of ADHD but also on improving emotional and social functioning.